Skip to main content
. 2021 Jul 14;109:209–216. doi: 10.1016/j.ijid.2021.07.016

Table 2.

Pulmonary function tests of patients at follow-up (3 months).

n n (%) Mean ± SD Median (IQR)
Delay between discharge and follow-up 156 101 ± 34 94 (77–119)
FEV1 (L) 156 2.73 ± 0.913
FEV1 (% predicted) 156 90.8 ± 20.8
FEV1 <80% predicted 156 34 (21.8)
FVC 156 3.41 ± 1.08
FVC (% predicted) 156 88.6 ± 18.2
FVC <80% predicted 156 43 (27.6)
Tiffeneau index % 156 79.7 ± 9.07
Tiffeneau index <70% 156 17 (10.9)
DLCO 132 6.04 ± 2.04
DLCO (% predicted) 132 71.6 ± 18.6
DLCO <75% predicted 132 72 (54.6)
DLCO_AV 132 1.25 ± 0.320
DLCO_AV (% predicted) 132 87.8 ± 20.6
DLCO_AV <80% predicted 132 46 (34.9)
TLC 85 5.36 ± 1.45
TLC (% predicted) 87 87.7 ± 21.9
TLC <80% predicted 87 31 (35.6)
FRC 73 3.32 ± 1.03
FRC (% predicted) 73 102.2 ± 29.2
FRC <80% predicted 73 14 (19.2)
RV 79 2.00 ± 0.742
RV (% predicted) 79 89.6 ± 30.0
RV <80% predicted 79 29 (36.7)
sGaw 72 0.940 ± 0.332
sGaw (% predicted) 58 87.3 ± 34.1
sGAw <80% predicted 58 24 (41.4)

FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; DLCO, diffusion lung capacity for carbon monoxide; AV, alveolar ventilation; TLC, total lung capacity; FRC, functional residual capacity; RV, residual volume; sGaw, specific conductance; SD, standard deviation; IQR, interquartile range.